BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37461358)

  • 21. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 22. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
    La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM
    World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.
    Li ZC; Yan J; Zhang S; Liang C; Lv X; Zou Y; Zhang H; Liang D; Zhang Z; Chen Y
    Eur Radiol; 2022 Aug; 32(8):5719-5729. PubMed ID: 35278123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.
    López-Pérez CA; Franco-Mojica X; Villanueva-Gaona R; Díaz-Alba A; Rodríguez-Florido MA; Navarro VG
    J Neurooncol; 2022 Jul; 158(3):369-378. PubMed ID: 35567713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated Determination of the H3 K27-Altered Status in Spinal Cord Diffuse Midline Glioma by Radiomics Based on T2-Weighted MR Images.
    Li J; Wang Y; Weng J; Qu L; Wu M; Guo M; Sun J; Hu G; Gong X; Liu X; Duan Y; Zhuo Z; Jia W; Liu Y
    AJNR Am J Neuroradiol; 2023 Dec; 44(12):1464-1470. PubMed ID: 38081676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-based classification of IDH mutation and 1p/19q codeletion status of gliomas using a 2.5D hybrid multi-task convolutional neural network.
    Chakrabarty S; LaMontagne P; Shimony J; Marcus DS; Sotiras A
    Neurooncol Adv; 2023; 5(1):vdad023. PubMed ID: 37152810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Performance of Machine Learning for Prediction of H3K27 M Mutation in Midline Gliomas: A Systematic Review and Meta-Analysis.
    Habibi MA; Aghaei F; Tajabadi Z; Mirjani MS; Minaee P; Eazi S
    World Neurosurg; 2024 Jun; 186():e7-e19. PubMed ID: 37995996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.
    Dufour C; Perbet R; Leblond P; Vasseur R; Stechly L; Pierache A; Reyns N; Touzet G; Le Rhun E; Vinchon M; Maurage CA; Escande F; Renaud F
    Brain Pathol; 2020 Jan; 30(1):179-190. PubMed ID: 31348837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative glioma segmentation in CT image using deep feature fusion model guided by multi-sequence MRIs.
    Tang F; Liang S; Zhong T; Huang X; Deng X; Zhang Y; Zhou L
    Eur Radiol; 2020 Feb; 30(2):823-832. PubMed ID: 31650265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report.
    Wang Q; Niu W; Pan H
    Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four methods to analyze H3K27M mutation in diffuse midline gliomas.
    Zhao H; Fang X; Xue B
    Pathol Res Pract; 2020 Sep; 216(9):153065. PubMed ID: 32825938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
    Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J
    Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
    Choi KS; Choi SH; Jeong B
    Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study for glioma classification using deep convolutional neural networks.
    Özcan H; Emiroğlu BG; Sabuncuoğlu H; Özdoğan S; Soyer A; Saygı T
    Math Biosci Eng; 2021 Jan; 18(2):1550-1572. PubMed ID: 33757198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H3K27M-mutant diffuse midline glioma presenting as synchronous lesions involving pineal and suprasellar region: A case report and literature review.
    Lim JX; Leong A; Tan AP; Tan CL; Nga VDW
    J Clin Neurosci; 2020 Nov; 81():144-148. PubMed ID: 33222904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
    Cluceru J; Interian Y; Phillips JJ; Molinaro AM; Luks TL; Alcaide-Leon P; Olson MP; Nair D; LaFontaine M; Shai A; Chunduru P; Pedoia V; Villanueva-Meyer JE; Chang SM; Lupo JM
    Neuro Oncol; 2022 Apr; 24(4):639-652. PubMed ID: 34653254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
    Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-based Identification and Classification of Major Intracranial Tumor Types by Using a 3D Convolutional Neural Network: A Retrospective Multi-institutional Analysis.
    Chakrabarty S; Sotiras A; Milchenko M; LaMontagne P; Hileman M; Marcus D
    Radiol Artif Intell; 2021 Sep; 3(5):e200301. PubMed ID: 34617029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age.
    Vuong HG; Ngo TNM; Le HT; Dunn IF
    J Neurooncol; 2022 Jul; 158(3):405-412. PubMed ID: 35606633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.